NCT06548737 Clinical Outcomes Following Primary Intracerebral Hemorrhage
| NCT ID | NCT06548737 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University |
| Condition | Stroke |
| Study Type | OBSERVATIONAL |
| Enrollment | 25,000 participants |
| Start Date | 2016-10-27 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 25,000 participants in total. It began in 2016-10-27 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators design an observational multi-center cohort study to provide contemporary information on the prevalence, characteristics, risk stratification，cost-effective ,treatments and prognosis of Chinese hospitalized adult patients with primary intracerebral hemorrhage.
Eligibility Criteria
Inclusion Criteria: \- We included adult patients who (1) admitted for primary ICH ; (2) underwent blood routine test (hemoglobin included) and CT scan as soon as they arrived at hospital; (3) were not treated with neurosurgical procedures. Exclusion Criteria: * We excluded patients who (1) had ICH secondary to known causes, including trauma, intracranial neoplasm and systemic diseases12, as well as anticoagulative agents; or had isolated intraventricular hemorrhage (IVH); (2) mRS \>2 before the current ICH episode (according to past medical records or description from guardians.
Contact & Investigator
Feng Gao, Dr
STUDY CHAIR
Zhejiang University
Frequently Asked Questions
Who can join the NCT06548737 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06548737 currently recruiting?
Yes, NCT06548737 is actively recruiting participants. Contact the research team at 2202012@zju.edu.cn for enrollment information.
Where is the NCT06548737 trial being conducted?
This trial is being conducted at Hangzhou, China.
Who is sponsoring the NCT06548737 clinical trial?
NCT06548737 is sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University. The principal investigator is Feng Gao, Dr at Zhejiang University. The trial plans to enroll 25,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.